VISTAGEN THERAPEUTICS, INC. Tenant Improvements
VISTAGEN THERAPEUTICS, INC. (VTGN) had Tenant Improvements of $26.90 thousand as of 2015-03-31, per its 10-K filed 2015-06-29.
Discontinued › Balance Sheet › Assets
us-gaap:TenantImprovements · last filed 2015-06-29
- 2015-03-31: Tenant Improvements $26.90K.
- 2014-03-31: Tenant Improvements $26.90K; Tenant Improvements as first filed $27.00K.
| Period end | Tenant Improvements | Tenant Improvements as first filed |
|---|---|---|
| 2015-03-31 | $26.90K 10-K · filed 2015-06-29 | |
| 2014-03-31 | $26.90K 10-K · filed 2015-06-29 | $27.00K 10-K · filed 2014-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |